Incidence of Gram‐negative bacteraemia in sepsis syndrome Implications for immunotherapy
Open Access
- 1 September 1994
- journal article
- clinical trial
- Published by Wiley in Anaesthesia
- Vol. 49 (9) , 751-754
- https://doi.org/10.1111/j.1365-2044.1994.tb04443.x
Abstract
The incidence of Gram‐negative bacteraemia in 100 patients with sepsis syndrome receiving antibiotics, and admitted to the Intensive Therapy Unit, was only 12%. If endotoxin antibody is only effective in bacteraemic patients and these results are confirmed, there would be little indication for its use in our Intensive Therapy Unit.Keywords
This publication has 12 references indexed in Scilit:
- A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative SepsisJAMA, 1991
- Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against EndotoxinNew England Journal of Medicine, 1991
- Blood culture technique: current controversiesJournal of Antimicrobial Chemotherapy, 1990
- Sepsis syndromeCritical Care Medicine, 1989
- ENDOTOXAEMIA: AN EARLY PREDICTOR OF SEPTICAEMIA IN FEBRILE PATIENTSThe Lancet, 1988
- Prognosis in Acute Organ-System FailureAnnals of Surgery, 1985
- Multiple-Organ FailureArchives of Surgery, 1985
- APACHE IICritical Care Medicine, 1985
- The grading of sepsisBritish Journal of Surgery, 1983
- Gram-negative bacteremiaThe American Journal of Medicine, 1980